Mark Rothera
Chief Executive Officer at VIRACTA THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Craig Tooman | M | 58 | 3 years | |
| Ivor Royston | M | 79 | 17 years | |
| Roger Pomerantz | M | 67 | 4 years | |
| Melody Burcar | F | 41 | 2 years | |
| Karim Smaira | M | - |
Genpharm Services
 Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | 12 years |
| Jon Ellis | M | 57 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Joanne Beck | M | 63 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Simone Song | F | 59 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 7 years |
| James Geraghty | M | 69 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Frank Thomas | M | 54 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom.
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | 6 years |
| Flavia Borellini | M | 64 | 3 years | |
| Kamel Ghammachi | M | - |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | 12 years |
| Sam Murphy | M | 47 | 5 years | |
| Stephen Rubino | M | 65 | 3 years | |
| Rhonda L. Hellums | F | 52 | 3 years | |
| Barry Simon | M | 59 | 3 years | |
| Jane Barlow | M | 63 | 3 years | |
| Thomas Darcy | M | 74 | 3 years | |
| Bobby Gaspar | M | 60 |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | 6 years |
| Jane Chung | F | 53 | 2 years | |
| Ashleigh Barreto | F | - | 3 years | |
| Marc Dunoyer | M | 71 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Glenn Steele | M | 79 | 9 years | |
| Martin Rexroad | M | - | 11 years | |
| Charles Rowland | M | 65 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Eric Pauwels | M | 63 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 15 years |
| Patric Nelson | M | - | 3 years | |
| Darrel Cohen | M | 59 | 1 years | |
| Donald Strickland | M | - | - | |
| Biljana Nadjsombati | F | - | 3 years | |
| Elmar Schnee | M | 65 |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | - |
| Ayman El-Guindy | M | - | 3 years | |
| Eric Fink | M | - | 2 years | |
| Cheryl A. Madsen | F | - | - | |
| Murad Husain | M | - | 10 years | |
| Stewart M. Brown | M | - | 2 years | |
| Michael Davidson | M | 67 | 3 years | |
| Ashkar Samy | M | - |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | - |
| Curtis Rambaran | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Chevallard | M | 44 | 5 years | |
| Marcio Souza | M | 45 | 6 years | |
| William T. Andrews | M | 60 | 4 years | |
| Benjamin Auspitz | M | 51 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | - |
| Ben Harshbarger | M | 55 | 4 years | |
| Alicia Secor | F | 62 | 6 years | |
| Nicolas Koebel | M | - | - | |
| Dawn Svoronos | F | 70 | 6 years | |
| Megan Sniecinski | F | 43 | 5 years | |
| Kurt J. W. Andrews | M | 54 | 9 years | |
| John Curnutte | M | 72 | 5 years | |
| Stephen J. Moloney | M | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 9 years |
| Cláudia Hirawat | F | 53 | 15 years | |
| Emily Hill | F | 44 | - | |
| Alexander Pasteur | M | 54 | - | |
| Robert Quinn | M | 41 | 4 years | |
| Adam Koppel | M | 54 | 4 years | |
| Shelly Vandertie | F | - | - | |
| Suzanne Bruhn | M | 60 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 14 years |
| Richard H. Aldrich | M | 69 | 2 years | |
| Steven Altschuler | M | 70 | 4 years | |
| Nicole Onetto | M | 71 | 2 years | |
| Michael L. Kranda | M | 69 | 12 years | |
| Axel Bolte | M | 52 | 11 years | |
| Ronald Renaud | M | 55 | 3 years | |
| Elise T. Wang | F | 64 | - | |
| Justine O'Malley | M | - | - | |
| Tu Yen Ong | M | 49 | - | |
| Anne Marie Conway | F | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 5 years |
| Morgan Conn | M | 42 | 16 years | |
| Alyssa Wyant | F | 49 | 2 years | |
| Jason Meyenburg | M | 47 | 1 years | |
| Andrew Komjathy | M | 61 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 7 years |
| Edward O'Mara | M | - | 4 years | |
| Sachiyo Minegishi | F | 46 | 4 years | |
| Frank DeRosa | M | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 7 years |
| Moya M. Daniels | F | 55 | 2 years | |
| Ran Zheng | F | 61 | 2 years | |
| Stephen Dilly | M | 64 |
CHIRON Biopharmaceuticals
| 3 years |
| Nancy M. Wyant | F | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 6 years |
| James G. Stout | M | 58 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 2 years |
| Susan E. Barrowcliffe | F | 66 |
CHIRON Biopharmaceuticals
| 2 years |
| Sylvie Grégoire | M | 62 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 6 years |
| Craig Wheeler | M | 63 |
CHIRON Biopharmaceuticals
| 5 years |
| Paul Hastings | M | 64 |
CHIRON Biopharmaceuticals
| 10 years |
| Stewart Craig | M | 63 | 3 years | |
| Peter Svennilson | M | 62 | 2 years | |
| Scott Wilhoit | M | 61 | 1 years | |
| Deanna M. Petersen | F | 62 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 6 years |
| Robert Spiegel | M | 73 | 5 years | |
| Jay Barth | M | 60 | 5 years | |
| Sue Cammarata | M | 67 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 years |
| Amanda Cray | F | - | 7 years | |
| Lisa Rojkjaer | M | 58 | 3 years | |
| Massimo Boriero | M | - | - | |
| Daniel van Plew | M | 51 |
CHIRON Biopharmaceuticals
| 2 years |
| William Hornung | M | 55 | 12 years | |
| Shane Kovacs | M | 50 | - | |
| Theresa Heggie | F | 63 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 years |
| R. Session | M | 45 | 4 years | |
| Tom Luby | M | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 73 | 73.00% |
| United Kingdom | 25 | 25.00% |
| United Arab Emirates | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Rothera
- Personal Network
